STRATIFICATION OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME BY MEASURING B-CELL HEALTH

被引：0
|
作者：
Verstappen, G. M. [1 ,2 ]
Tempany, J. C. [1 ]
Cheon, H. [3 ]
Farchione, A. [1 ,4 ]
Downie-Doyle, S. [5 ,6 ]
Rischmueller, M. [5 ,6 ]
Duffy, K. R. [3 ]
Kroese, F. G. M. [2 ]
Bootsma, H. [2 ]
Hodgkin, P. D. [1 ,4 ]
Bryant, V. L. [1 ,4 ]
机构：
[1] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia
[2] Univ Groningen, Univ Med Ctr Groningen, Rheumatol & Clin Immunol, Groningen, Netherlands
[3] Hamilton Inst, Maynooth, Kildare, Ireland
[4] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia
[5] Queen Elizabeth Hosp, Adelaide, SA, Australia
[6] Univ Adelaide, Adelaide, SA, Australia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3507
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0144
引用
收藏
页码：1368 / 1369
页数：2
相关论文
共 50 条
  • [31] Impaired Bone Health in Patients with Primary Sjogren's Syndrome
    Hu, Zaiying
    Zhu, Shanglin
    Liao, Zetao
    Zhang, Baiyu
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [32] B-CELL SUBSETS AS ADDITIONAL DIAGNOSTIC TOOL FOR PRIMARY SJOGREN'S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS
    Benevolenskaya, S.
    Kudryavtsev, I.
    Serebriakova, M.
    Grigor'eva, I.
    Budkova, A.
    Zammoeva, D.
    Motorin, D.
    Zaritskey, A.
    Lapin, S.
    Maslyanskiy, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1311 - 1312
  • [33] B-cell depletion with rituximab in the treatment of primary Sjogren's syndrome: what have we learnt?
    Grigoriadou, S.
    Chowdhury, F.
    Pontarini, E.
    Tappuni, A.
    Bowman, S. J.
    Bombardieri, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : S217 - S224
  • [34] B-cell activity markers are associated with different disease activity domains in primary Sjogren's syndrome
    James, Katherine
    Chipeta, Chimwemwe
    Parker, Antony
    Harding, Stephen
    Cockell, Simon J.
    Gillespie, Colin S.
    Hallinan, Jennifer
    Barone, Francesca
    Bowman, Simon J.
    Ng, Wan-Fai
    Fisher, Benjamin A.
    RHEUMATOLOGY, 2018, 57 (07) : 1222 - 1227
  • [35] B-cell tolerance breakdown in Sjogren's Syndrome: Focus on BAFF
    Varin, Marie-Michele
    Le Pottier, Laetitia
    Youinou, Pierre
    Saulep, Damien
    Mackay, Fabienne
    Pers, Jacques-Olivier
    AUTOIMMUNITY REVIEWS, 2010, 9 (09) : 604 - 608
  • [36] ASSOCIATION OF PATHOGENIC AND REGULATORY B-CELL SUBSETS WITH CLINICAL AND HISTOLOGICAL FEATURES IN PRIMARY SJOGREN'S SYNDROME
    Carubbi, F.
    Alunno, A.
    Cipriani, P.
    Di Benedetto, P.
    Liakouli, V.
    Ruscitti, P.
    Berardicurti, O.
    Di Bartolomeo, S.
    Gerli, R.
    Giacomelli, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 880 - 880
  • [37] Re: "Splenic marginal zone B-cell lymphoma associated with primary Sjogren's syndrome" - Reply
    Nishiyama, S
    Miyawaki, S
    CLINICAL RHEUMATOLOGY, 2005, 24 (02) : 188 - 188
  • [38] Prediction of monoclonal B-cell expansion in Sjogren's syndrome.
    Radfar, L
    Kok, M
    Kleiner, D
    Sorbara, I
    Raffeld, M
    Pillemer, S
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S254 - S254
  • [39] Clonal B-cell reactions in Sjogren's syndrome and autoimmunethyroiditis Hashimoto
    Tiemann, M
    Asbeck, R
    Wacker, HH
    PATHOLOGE, 1996, 17 (04): : 289 - 295
  • [40] CHARACTERISTICS OF PERIPHERAL BLOOD B-CELL SUBSETS IN PATIENTS WITH SJOGREN SYNDROME
    Torgashina, A.
    Sokol, E.
    Khvan, J.
    Chalcev, B.
    Tabakov, D.
    Glukhova, S.
    Golovina, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 196 - 196
12345